Open Accessibility Menu

Support Groups

You Do Not Have to Go Through This Alone

The Katzen Center understands how difficult a cancer diagnosis can be for the whole family. We offer a number of supportive and educational programs meeting weekly or monthly to help you through your diagnosis. All support groups and meetings are open to all metro Washington, DC residents at no charge. Parking and light meals provided at many meetings.

Active Treatment Group (All Cancers)

The active treatment group is a general cancer support group open to any cancer patient currently undergoing treatment. The group meets on a weekly basis to discuss common themes and give support. This group is open to all diagnoses.

Brain Tumor Support Group

This group is open to patients/survivors with brain tumors and their caregivers. We meet to discuss common themes and give support. Occasionally outside professional speakers provide discussion on key topics.

Breast Cancer Support Group

This group is open to any woman who is being treated or has been treated for breast cancer. The group alternates between educational programming and support.

Caregivers’ Support Group

This group is for family members and friends who are involved with cancer patients. The caregiver support group is a place to share common concerns, get and give advice, and learn coping skills. It is open to anyone who has a family member with cancer.

Kids’ Club

Kids’ Club is open to children ages 6-13 who have a family member with cancer. Most sessions are centered on art activities. This group is professionally facilitated by a licensed social worker and an art therapist.

Multiple Myeloma Support Group

This group is open to patients, survivors and their caregivers. Speakers are present at most meetings to provide education and offer support. A light dinner is provided.

Prostate Cancer Educational Group

This educational group is open to patients, survivors and their caregivers. Speakers are present at most meetings.

Gentle Yoga

This class is for anyone living with cancer and their caregivers. Yoga provides coping tools for the physical and psychological challenges of a cancer diagnosis and treatment.

Young Adult Support Group

The Young Adult Group is open to patients with any diagnoses between the ages of 19-39. The group discusses the unique challenges of adjusting to cancer at this age, employment issues, relationship challenges and coping strategies. Please call for location and registration information.

Most support groups meet at 2150 Pennsylvania Avenue, NW, Washington, DC - one block away from the Foggy Bottom Metro station. For support group dates, times and locations, contact us at (202) 677-6229. To RSVP for a support group or for more information, click here.

Clinical Trials

  • Comparing Group Approaches to Improve Insomnia Symptoms Among Breast Cancer Survivors
    We are inviting women diagnosed with stage I-III breast cancer who have completed active treatment (e.g. surgery, chemotherapy, radiation) to participate in this research study. Through this study we will examine if our mind and body programs improve some of the long term effects of breast cancer treatment such as insomnia. This is a pilot phase of the study. This means that we are interested in feasibility of the program and will ask for your feedback about things you like and do not like about the program.
  • Combination immunotherapy with Herceptin and theHER2 vaccine E75 in low and intermediate HER2-expressing breast cancer patients to prevent recurrence
    This is a randomized trial for after all neo or adjuvant therapy is complete for women are Her2 1+ or HER2 2+
  • A Randomized Phase III Trial of Palbociclib with Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+)/ Human Epidermal Growth Factor Receptor 2 (HER2)-Negative early Breast Cancer (PALLAS Study)
    The purpose of the PALLAS study is to determine whether the addition of palbociclib to adjuvant endocrine therapy will improve outcomes over endocrine therapy alone for HR+/HER2- early breast cancer.
  • A Phase 3 Randomized Study Comparing Perioperative Nivolumab vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
    This randomized phase III trial compares nephrectomy (surgery to remove a kidney or part of a kidney) with or without nivolumab in treating patients with kidney cancer that is limited to a certain part of the body (localized). Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Giving nivolumab before nephrectomy may make the tumor smaller and reduce the amount of normal tissue that needs to be removed, and after nephrectomy to increase survival. It is not yet known whether nivolumab and nephrectomy is more effective than nephrectomy alone in treating patients with kidney cancer.
  • A Open-Label, Multicenter, Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination with Letrozole for The Treatment of men and Pre/Postmenopausal Women With Hormone Receptor-Positive (HR+) HER-Negative (HER2-) Advanced Breast Cancer (aBC) with No Prior Hormonal Therapy for Advanced Disease
    The purpose of the PALLAS study is to determine whether the addition of palbociclib to adjuvant endocrine therapy will improve outcomes over endocrine therapy alone for HR+/HER2- early breast cancer.
  • A Global, Prospective, Non-Interventional, Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Patients-the INSIGHT-MM study
    The objective of this study is to describe contemporary, real-world patterns of patient characteristics, clinical disease presentation, therapeutic regimen chosen, and clinical outcomes in patients with newly diagnosed multiple myeloma and patients with relapsed/refractory multiple myeloma.